nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment
|
Tozuka, Takehiro |
|
|
144 |
C |
p. 71-75 |
artikel |
2 |
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?
|
Popat, Sanjay |
|
|
144 |
C |
p. 76-84 |
artikel |
3 |
Concurrent ERBB2 missense mutations D769Y and D742 N Are Novel Acquired Mechanism of Gefitinib Resistance but Responds to Gefitinib plus Pyrotinib
|
Zhou, Yuling |
|
|
144 |
C |
p. 90-91 |
artikel |
4 |
Contents
|
|
|
|
144 |
C |
p. v-vi |
artikel |
5 |
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations
|
Scheffler, Matthias |
|
|
144 |
C |
p. 40-48 |
artikel |
6 |
Corrigendum to ‘Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand’ [Lung Cancer volume (124) 233-240]
|
|
|
|
144 |
C |
p. 98 |
artikel |
7 |
Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand
|
Jaine, Richard |
|
|
144 |
C |
p. 99-106 |
artikel |
8 |
Editorial Board
|
|
|
|
144 |
C |
p. iii |
artikel |
9 |
Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis
|
Breadner, Daniel |
|
|
144 |
C |
p. 57-63 |
artikel |
10 |
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
|
Stockhammer, Paul |
|
|
144 |
C |
p. 20-29 |
artikel |
11 |
Immune checkpoint inhibitors in special populations. A focus on advanced lung cancer patients
|
Escoin-Perez, Corina |
|
|
144 |
C |
p. 1-9 |
artikel |
12 |
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer
|
Peters, Solange |
|
|
144 |
C |
p. 10-19 |
artikel |
13 |
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC
|
Mazzaschi, Giulia |
|
|
144 |
C |
p. 30-39 |
artikel |
14 |
Letter to the editor concerning ‘Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer’
|
Chen, Donglai |
|
|
144 |
C |
p. 92 |
artikel |
15 |
LTBP1-ALK: A novel fusion identified in malignant pleural effusions from a patient with advanced lung adenocarcinoma
|
Qian, HuiWen |
|
|
144 |
C |
p. 93-97 |
artikel |
16 |
Serum cotinine verification of self-reported smoking status among adults eligible for lung cancer screening in the 1999-2018 National Health and Nutrition Examination Survey
|
Liu, Bian |
|
|
144 |
C |
p. 49-56 |
artikel |
17 |
The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands
|
de Ruiter, Julianne C |
|
|
144 |
C |
p. 64-70 |
artikel |
18 |
Treatment of pembrolizumab and chemotherapy results in pulmonary lymphoepithelioma-like carcinoma progression through harboring secondary amplification of PI3KCA and IL-7R
|
Chen, Mei-ting |
|
|
144 |
C |
p. 87-89 |
artikel |
19 |
Upstaging, centrality and survival in early stage non-small cell lung cancer video-assisted surgery
|
Nachira, Dania |
|
|
144 |
C |
p. 85-86 |
artikel |